A novel, synthetic DNA vaccine developed at The Wistar Institute induces protective immunity against Mayaro virus (MAYV), a mosquito-borne infection endemic to South America, that has the potential to...

Oxford University, through its innovation arm Oxford University Innovation (OUI), has entered into an option agreement for a universal influenza vaccine with US-based startup Blue Water Vaccines (BWV),...

A study led by a University of Manitoba researcher has brought science one step closer to using the chickenpox virus to develop a vaccine against HIV. “Varicella-zoster virus, which causes chickenpox,...

Merck announced this week that V114, the company’s investigational 15-valent pneumococcal conjugate vaccine, has received Breakthrough Therapy Designation from the U.S. Food and Drug Administration...

Biotech company, Valneva SE, announced today positive initial booster data and final Phase 1 data for its leading, unique Lyme disease vaccine candidate VLA15. To investigate whether a VLA15 booster...

Takeda Pharmaceutical Company Limited today announced that the pivotal Phase 3 trial of its dengue vaccine candidate met the primary efficacy endpoint. This first analysis of the Tetravalent Immunization...

The Malaysian Ministry of Health reports there is much anti-vaccine propaganda on social media, which is influencing the public to reject life-saving vaccinations based on bad information. The Ministry...

The Ministry of Health reports the measles vaccination campaign in the country has completed its fourth week and  63% of the vaccines had been administered as of Jan. 11. The country is carrying out...

Earlier this week, Senate Minority Leader, Chuck Schumer of New York made a statement concerning the shortage of the popular shingles vaccine, Shingrix and seemed to link it to the current government...

Biotech company, Valneva announced today the signing of a new $59 million contract with the U.S. government Department of Defense for the supply of its Japanese encephalitis (JE) vaccine IXIARO® . Valneva’s...